| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8859cb0f0a243827ac7b5ab6ddc23d57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ecc01dbbe855d729f0c7d68a3e5cd8a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
| filingDate |
2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca261b03cdd7a320226f80a12085fd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fc4decdf078a2ce9ba2c9fecb2a9896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfd11ba362fd9d47e0a36aa17806b4fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39513daa2ce62080fa87e915448371e2 |
| publicationDate |
2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018073414-A1 |
| titleOfInvention |
Lepista flaccida intended to be used for treating a disease caused by a nonsense mutation |
| abstract |
The invention concerns the use of Lepista flaccida intended for treating a disease caused by a nonsense mutation of a gene resulting in the premature introduction of a UGA and/or UAA stop codon. It also concerns a Lepista flaccida extract comprising at least 2,6-diaminopurine (DAP) obtained by maceration or infusion of Lepista flaccida in a solvent. It also concerns this Lepista flaccida extract intended to be used for treating a disease caused by a nonsense mutation of a gene resulting in the premature introduction of a UGA and/or UAA stop codon. It additionally concerns a therapeutic treatment method comprising a step of administering Lepista flaccida or a Lepista flaccida extract or a pharmaceutical composition comprising this Lepista flaccida extract. The invention is applicable in the pharmaceutical field, in particular for treating diseases caused by a nonsense mutation of a gene resulting in the premature introduction of a UGA and/or UAA stop codon. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3528815-B1 |
| priorityDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |